Table of Contents

Overview

The B2M (β2-microglobulin) gene plays a crucial role in the function of the major histocompatibility complex (MHC) class I molecules, which are essential for immune system recognition of infected or malignant cells.

Experimental Evidence

B2M mutations in B-cell lymphomas, particularly in DLBCL and PMBCL, lead to reduced MHC class I expression, enabling tumor cells to evade immune detection and destruction by cytotoxic T cells. This is often accompanied by mutations in the β2-Microglobulin gene, which further aids in immune evasion.1

Relevance tier by entity

Entity Tier Description
BL 2 Role of B2M mutations in BL requires confirmation
DLBCL 1 High-confidence DLBCL gene
FL 1 High-confidence FL gene
MCL 2 Role of B2M mutations in MCL requires confirmation
PMBL 1 High-confidence PMBL gene

Mutation incidence in large patient cohorts (GAMBL reanalysis)

DLBCL

Entity Collection N mutated Incidence 95% CI
DLBCL GAMBL without Reddy 1,089 156 0.1433 [0.1224,0.1641]
DLBCL GAMBL with Reddy 2,088 277 0.1327 [0.1181,0.1472]
DLBCL BC 231 29 0.1255 [0.0828,0.1683]
DLBCL Dana-Farber 303 38 0.1254 [0.0881,0.1627]
DLBCL NCI 470 73 0.1553 [0.1226,0.1881]
DLBCL Reddy 999 121 0.1211 [0.1009,0.1414]
DLBCL DLBCL_ICGC 85 16 0.1882 [0.1051,0.2713]

FL

pathology Collection N mutated Incidence CI
FL GAMBL without Crouch 642 41 0.0639 [0.0449,0.0828]
FL GAMBL with Crouch 1,189 80 0.0673 [0.053,0.0815]
FL BC 379 22 0.0580 [0.0345,0.0816]
FL Kalmbach 164 6 0.0366 [0.0079,0.0653]
FL Crouch 547 39 0.0713 [0.0497,0.0929]
FL FL_ICGC 99 13 0.1313 [0.0648,0.1978]

MCL

pathology Collection N mutated Incidence CI
MCL GAMBL 160 1 0.0037 [0,0.0131]
MCL BC_MCL 103 1 0.0097 [0,0.0286]
MCL Barcelona 57 0 0.0018 [0,0.0126]

BL

pathology Collection N mutated Incidence CI
BL GAMBL without Panea 309 6 0.0175 [0.0029,0.0321]
BL GAMBL without ICGC/Zhou 320 8 0.0246 [0.0077,0.0416]
BL GAMBL with Panea 410 9 0.0195 [0.0061,0.0329]
BL BLGSP 219 5 0.0228 [0.003,0.0426]
BL Zhou/ICGC 90 1 0.0111 [0,0.0328]
BL Panea 101 3 0.0297 [0,0.0628]

Mutation pattern and selective pressure estimates

Entity Missense dN/dS Nonsense dN/dS Q value
BL 13.3547 28.5896 0.0069
FL 36.5331 147.2290 0.0000
DLBCL 12.2654 61.8372 0.0000

Cannot include /tables/hotspots/hotspots_B2M.md - does not exist yet

Structure with HotMAPS hotspots

Visualizations

Protein

View coding variants in ProteinPaint hg19 or hg38

Genome

View all variants in GenomePaint hg19 or hg38

Expression

History

%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%% timeline title Publication timing 2011-07-27 : Morin : DLBCL 2012-03-06 : Lohr : DLBCL 2013-01-01 : Zhang : DLBCL 2013-08-15 : Morin : DLBCL 2015-02-12 : Reichel : PMBL 2017-05-01 : Albuquerque : DLBCL 2017-10-10 : Reddy : DLBCL 2018-05-01 : Chapuy : DLBCL 2018-10-01 : Arthur : DLBCL 2020-07-30 : Pararajalingam : MCL 2021-05-05 : Hubschmann : DLBCL

References

1.
Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R. Combined genetic inactivation of Β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 2011 Dec 13;20(6):728–740. PMCID: PMC3660995
2.
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJM, Connors JM, Hirst M, Gascoyne RD, Marra MA. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011 Jul 27;476(7360):298–303. PMCID: PMC3210554
3.
Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G, Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE, Marra MA, Johnson NA, Scott DW, Morin RD. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020 Jul 30;136(5):572–584. PMCID: PMC7440974
4.
Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E, Roshal M. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood. 2015 Feb 12;125(7):1061–1072.

Citing

If you use the information or data from this site, please cite

Krysta Coyle, Kostiantyn Dreval, Daniel Hodson and Ryan D. Morin. Audit of B-cell cancer genes. Blood Adv (2025) 9 (8): 2019–2031.

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.